Profile data is unavailable for this security.
About the company
Jiangsu Bioperfectus Technologies Co Ltd is a China-based company mainly engaged in the research and development, production and sales of in vitro diagnostic products. The Company's products mainly include in vitro diagnostic reagents, supporting testing instruments and in vitro testing services. Its products are mainly used in the fields of infectious disease prevention and control, clinical testing, large-scale population screening, as well as prenatal and postnatal care management. The Company mainly conducts its businesses in domestic and overseas markets.
- Revenue in CNY (TTM)400.25m
- Net income in CNY-314.32m
- Incorporated2010
- Employees684.00
- LocationJiangsu Bioperfectus Technologies Co LtdNo. 837, Yaocheng AvenueTAIZHOU 225300ChinaCHN
- Phone+86 52 380225599
- Fax+86 52 386201617
- Websitehttps://www.bioperfectus.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hunan Warrant Pharmaceutical Co Ltd | 1.45bn | 222.11m | 4.03bn | 1.16k | 18.15 | 2.26 | -- | 2.78 | 2.37 | 2.37 | 15.44 | 19.01 | 0.6713 | 1.50 | 8.93 | 1,246,491.00 | 9.31 | 11.21 | 11.21 | 14.05 | 64.09 | 69.00 | 13.88 | 13.96 | 3.02 | -- | 0.0252 | 8.05 | 10.84 | 18.50 | 15.60 | 19.02 | 24.49 | -- |
| Sinotherapeutics Inc | 368.86m | 76.25m | 4.13bn | 260.00 | 54.11 | 3.44 | -- | 11.18 | 0.1682 | 0.1682 | 0.8137 | 2.65 | 0.275 | 3.08 | 5.83 | 1,418,710.00 | 5.69 | -- | 6.09 | -- | 51.77 | -- | 20.67 | -- | 9.09 | -- | 0.00006 | -- | 21.13 | -- | -34.29 | -- | -- | -- |
| Jiangsu Bioperfectus Technologies Co Ltd | 400.25m | -314.32m | 4.21bn | 684.00 | -- | 1.22 | -- | 10.52 | -5.36 | -5.36 | 6.83 | 58.77 | 0.0915 | 0.8592 | 1.57 | 585,153.50 | -7.19 | 25.41 | -8.36 | 31.26 | 63.20 | 63.37 | -78.53 | 32.86 | 6.05 | -- | 0.086 | 30.54 | -92.72 | 11.81 | -120.45 | -- | 2.43 | -- |
| Jinyao Pharmaceutical Co Ltd | 3.66bn | 107.59m | 4.32bn | 2.68k | 40.13 | 1.43 | -- | 1.18 | 0.0984 | 0.0984 | 3.35 | 2.76 | 0.5738 | 2.28 | 9.37 | 1,365,219.00 | 2.33 | 1.91 | 4.17 | 3.40 | 42.61 | 46.33 | 4.06 | 3.31 | 0.7584 | 27.18 | 0.2064 | 44.40 | 2.55 | 9.28 | 230.60 | -4.22 | -9.58 | 9.21 |
| Shanghai OPM Biosciences Co Ltd | 254.91m | 49.43m | 4.33bn | 285.00 | 87.82 | 2.01 | -- | 16.98 | 0.4294 | 0.4294 | 2.22 | 18.80 | 0.1095 | 2.07 | 2.54 | 894,431.90 | 2.09 | 4.34 | 2.16 | 4.65 | 58.86 | 58.31 | 19.06 | 23.40 | 19.91 | -- | 0.0315 | 45.38 | -17.41 | 48.34 | -48.72 | -- | 6.09 | -- |
| Assure Tech Hangzhou Co Ltd | 511.29m | 160.91m | 4.39bn | 791.00 | 27.31 | 0.8485 | -- | 8.60 | 1.27 | 1.27 | 4.02 | 40.75 | 0.0799 | 1.52 | 2.67 | 646,379.60 | 2.51 | 31.83 | 2.94 | 38.97 | 38.56 | 65.82 | 31.47 | 47.86 | 8.26 | -- | 0.0166 | 16.05 | -91.84 | 25.18 | -95.35 | 33.51 | 78.77 | -- |
| Yabao Pharmaceutical Group Co Ltd | 2.88bn | 204.43m | 4.41bn | 4.14k | 22.26 | 1.51 | -- | 1.53 | 0.2754 | 0.2754 | 3.81 | 4.05 | 0.7193 | 2.98 | 6.79 | 695,432.10 | 4.52 | 2.82 | 5.90 | 3.97 | 56.00 | 59.20 | 6.29 | 4.19 | 1.62 | 47.13 | 0.0675 | 43.74 | 7.05 | -0.0572 | 90.71 | -6.10 | 7.98 | -9.71 |
Data as of Jun 03 2024. Currency figures normalised to Jiangsu Bioperfectus Technologies Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
8.25%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Rongtong Fund Management Co., Ltd.as of 31 Dec 2023 | 2.72m | 4.63% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 1.58m | 2.70% |
| Lion Fund Management Co., Ltd.as of 31 Dec 2023 | 188.37k | 0.32% |
| Maxwealth Fund Management Co., Ltd.as of 31 Dec 2023 | 116.87k | 0.20% |
| China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 70.36k | 0.12% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2023 | 60.57k | 0.10% |
| Dimensional Fund Advisors LPas of 09 May 2024 | 52.99k | 0.09% |
| Manulife TEDA Fund Management Co., Ltd.as of 31 Dec 2023 | 19.85k | 0.03% |
| China Merchants Fund Management Co., Ltd.as of 31 Dec 2023 | 16.71k | 0.03% |
| Acadian Asset Management LLCas of 30 Sep 2023 | 11.51k | 0.02% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
